Tero Ylisaukko-oja, Author at MedEngine

News Nordic Insights

Winning Over Healthcare Professionals in a Noisy Digital World

Let’s be honest: when it comes to digital communication, pharma has historically lagged behind. Winning Over Healthcare Professionals in a Noisy Digital World: While other…

Tero Ylisaukko-oja28/04/2025

News Nordic Insights

Rare Disease Era: Why Pharma’s Playbook Needs a Rewrite

Medicines for rare diseases are no longer a niche category—they’re dominating drug approvals and reshaping the industry. In 2024, over one-third of all EMA positive…

Tero Ylisaukko-oja02/04/2025

News MedEngine Warmly Welcomes Nordic Insights

The Nordic Opportunity: Turning Real-World Data into a Rare Disease Research Powerhouse

Over the past decade, rare diseases have gone from a niche to a major focus in pharma, thanks to regulatory incentives and advances in precision…

Tero Ylisaukko-oja21/02/2025

News

Saku Torvinen joins MedEngine to launch Market Access services

MedEngine Oy announced today that Saku Torvinen, PhD, joins MedEngine Oy as Director of Market Access. At MedEngine, he will be responsible for the launch…

Tero Ylisaukko-oja11/03/2021

News

MedEngine acquires the Institute of Applied Economics and Health Research ApS (ApHER) to offer Nordic real-world data solutions to global pharmaceutical companies

MedEngine Oy announced today that it has acquired the Institute of Applied Economics and Health Research ApS (ApHER), a leading Danish medical data science company.…

Tero Ylisaukko-oja04/03/2021

In Press

In Press: Vedolizumab may have a real-life corticosteroid sparing effect

Vedolizumab may have a corticosteroid sparing effect in real-world clinical practice, a new Finnish study reveals. The incidence of inflammatory bowel disease (IBD), which include ulcerative colitis…

Tero Ylisaukko-oja15/02/2019

News

BC Platforms and MedEngine Announce a Strategic Partnership to Launch New Models for Global Medical Data Science Services

MedEngine Oy, a company specialized in high-quality medical data science services, and BC Platforms AG, a world leader in genomic data management and analytics, today…

Tero Ylisaukko-oja09/01/2019

Insight

Finland has major competitive advantages for RWE research shows recent study conducted by MedEngine

Finland is in a good position to begin building a globally competitive ecosystem for real-world data (RWD) research, a qualitative survey conducted by MedEngine reveals.…

Tero Ylisaukko-oja19/12/2018

News

MedEngine ja DRA Consulting yhteistyöhön Market Access -palveluissa: tutkimustietoa ja strategista osaamista liiketoiminnan moottoriksi

Suomalaiset lääkealan asiantuntijapalveluihin erikoistuneet DRA Consulting Oy ja MedEngine Oy ovat aloittaneet Pohjoismaat kattavan yhteistyön. Yritysten keskeisenä tavoitteena on kehittää entistä tehokkaampia Market Access -palveluita…

Tero Ylisaukko-oja04/10/2018

News

MedEngine achieves very strong growth in 2017 by combining medical data with pharmaceutical business expertise

MedEngine, a premium service provider for pharmaceutical and health technology industries, reports a strong financial result in 2017. The company’s revenue grew 61% to 1.6…

Tero Ylisaukko-oja22/05/2018

Winning Over Healthcare Professionals in a Noisy Digital World

Rare Disease Era: Why Pharma’s Playbook Needs a Rewrite

The Nordic Opportunity: Turning Real-World Data into a Rare Disease Research Powerhouse

Saku Torvinen joins MedEngine to launch Market Access services

MedEngine acquires the Institute of Applied Economics and Health Research ApS (ApHER) to offer Nordic real-world data solutions to global pharmaceutical companies

In Press: Vedolizumab may have a real-life corticosteroid sparing effect

BC Platforms and MedEngine Announce a Strategic Partnership to Launch New Models for Global Medical Data Science Services

Finland has major competitive advantages for RWE research shows recent study conducted by MedEngine

MedEngine ja DRA Consulting yhteistyöhön Market Access -palveluissa: tutkimustietoa ja strategista osaamista liiketoiminnan moottoriksi

MedEngine achieves very strong growth in 2017 by combining medical data with pharmaceutical business expertise

Recent Posts

Get in Touch

Find Us

Sign up for our newsletter